Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
Open Access
- 25 August 2026
- journal article
- correction
- Published by Springer Nature in Nature Medicine
- Vol. 32 (10) , 3913